RxDoctor Payments Data

Jiasen Wang, MD

Dermatology · Albuquerque, NMNPI 1760045355

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Sanofi at 27.2% of the total. Reporting peaked in 2022 at $1,287 and has fallen 84.2% since, to $204 in 2025.

$2,638in general payments, 2019–2025

Across 46 payments — averaging $57.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$718
  • AbbVie$576
  • E.r. Squibb & Sons, L.L.C.$365
  • Kyowa Kirin, Inc.$230
  • Amgen$197
  • Boehringer Ingelheim$139
  • plus $415 from 5 others

What the payments were for

  • Food & beverage$2,638100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,638 in reported general payments places this provider in the 65th percentile of 52 dermatology providers in New Mexico.

See all dermatology providers in New Mexico

Medicare billing

Part B allowed, 2024
$122,067
Medicare patients
346
Services billed
1,556

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab12$44,352
Triamcinolone Acetonide73$1,739
Fluocinonide30$1,010
Fluorouracil18$977
Clobetasol Propionate16$636
Doxycycline Hyclate25$458
Ketoconazole27$427
Minoxidil12$157

Paid to pharmacies, not to this prescriber.

Other dermatology in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →